Summit Therapeutics Inc (NAS:SMMT)
$ 19.17 0.17 (0.89%) Market Cap: 14.01 Bil Enterprise Value: 13.56 Bil PE Ratio: 0 PB Ratio: 32.20 GF Score: 29/100